228 related articles for article (PubMed ID: 15518636)
21. Chronic angiotensin II infusion modulates angiotensin II type I receptor expression in the subfornical organ and the rostral ventrolateral medulla in hypertensive rats.
Nunes FC; Braga VA
J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):440-5. PubMed ID: 21393361
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II AT1 receptor blockade decreases lipopolysaccharide-induced inflammation in the rat adrenal gland.
Sanchez-Lemus E; Murakami Y; Larrayoz-Roldan IM; Moughamian AJ; Pavel J; Nishioku T; Saavedra JM
Endocrinology; 2008 Oct; 149(10):5177-88. PubMed ID: 18556352
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II regulation of tyrosine hydroxylase gene expression in the neuronal cultures of normotensive and spontaneously hypertensive rats.
Yu K; Lu D; Rowland NE; Raizada MK
Endocrinology; 1996 Aug; 137(8):3566-76. PubMed ID: 8754788
[TBL] [Abstract][Full Text] [Related]
24. Peripheral administration of AT1 receptor blockers and pressor responses to central angiotensin II and sodium.
Zhang J; Leenen FH
Can J Physiol Pharmacol; 2001 Oct; 79(10):861-7. PubMed ID: 11697745
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II plays an important role in maintaining blood pressure in postmenopausal women receiving hormone replacement therapy.
Sumino H; Ichikawa S; Miya Y; Sakamaki T; Kurabayashi M
Am J Hypertens; 2005 Oct; 18(10):1340-6. PubMed ID: 16202859
[TBL] [Abstract][Full Text] [Related]
26. Sympatho-inhibitory properties of various AT1 receptor antagonists.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061
[TBL] [Abstract][Full Text] [Related]
27. Decreased hypothalamic and adrenal angiotensin II receptor expression and adrenomedullary catecholamines in transgenic mice with impaired glucocorticoid receptor function.
Jain P; Armando I; Juorio AV; Barden N; Benicky J; Saavedra JM
Neuroendocrinology; 2004; 80(3):171-80. PubMed ID: 15583474
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II inhibition reduces stress sensitivity of hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats.
Raasch W; Wittmershaus C; Dendorfer A; Voges I; Pahlke F; Dodt C; Dominiak P; Jöhren O
Endocrinology; 2006 Jul; 147(7):3539-46. PubMed ID: 16574788
[TBL] [Abstract][Full Text] [Related]
29. Rapid, dynamic changes in glomerular permeability to macromolecules during systemic angiotensin II (ANG II) infusion in rats.
Axelsson J; Rippe A; Oberg CM; Rippe B
Am J Physiol Renal Physiol; 2012 Sep; 303(6):F790-9. PubMed ID: 22718887
[TBL] [Abstract][Full Text] [Related]
30. Female spontaneously hypertensive rats are more dependent on ANG (1-7) to mediate effects of low-dose AT1 receptor blockade than males.
Zimmerman MA; Harris RA; Sullivan JC
Am J Physiol Renal Physiol; 2014 May; 306(10):F1136-42. PubMed ID: 24647710
[TBL] [Abstract][Full Text] [Related]
31. Differential kinetics of circulating angiotensin IV and II after treatment with angiotensin II type 1 receptor antagonist and their plasma levels in patients with chronic renal failure.
Shibasaki Y; Mori Y; Tsutumi Y; Masaki H; Sakamoto K; Murasawa S; Maruyama K; Moriguchi Y; Tanaka Y; Iwasaka T; Inada M; Matsubara H
Clin Nephrol; 1999 Feb; 51(2):83-91. PubMed ID: 10069643
[TBL] [Abstract][Full Text] [Related]
32. Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats.
Naruse M; Tanabe A; Sato A; Takagi S; Tsuchiya K; Imaki T; Takano K
Hypertension; 2002 Jul; 40(1):28-33. PubMed ID: 12105134
[TBL] [Abstract][Full Text] [Related]
33. Effects of AT1 receptor antagonist and spironolactone on cardiac expression of ET-1 mRNA in SHR-SP/Izm.
Naruse M; Tanabe A; Hara Y; Takagi S; Imaki T; Takano K
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S1-3. PubMed ID: 15838251
[TBL] [Abstract][Full Text] [Related]
34. Peripherally administered angiotensin II AT1 receptor antagonists are anti-stress compounds in vivo.
Pavel J; Benicky J; Murakami Y; Sanchez-Lemus E; Saavedra JM
Ann N Y Acad Sci; 2008 Dec; 1148():360-6. PubMed ID: 19120129
[TBL] [Abstract][Full Text] [Related]
35. Increased angiotensin II AT(1) receptor expression in paraventricular nucleus and hypothalamic-pituitary-adrenal axis stimulation in AT(2) receptor gene disrupted mice.
Armando I; Terrón JA; Falcón-Neri A; Takeshi I; Häuser W; Inagami T; Saavedra JM
Neuroendocrinology; 2002 Sep; 76(3):137-47. PubMed ID: 12218346
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II AT
Marchese NA; Paz MC; Caeiro X; Dadam FM; Baiardi G; Perez MF; Bregonzio C
Neuroscience; 2017 Jan; 340():521-529. PubMed ID: 27856342
[TBL] [Abstract][Full Text] [Related]
37. Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.
Saavedra JM
Cell Mol Neurobiol; 2005 Jun; 25(3-4):485-512. PubMed ID: 16075377
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress.
Armando I; Volpi S; Aguilera G; Saavedra JM
Brain Res; 2007 Apr; 1142():92-9. PubMed ID: 17306778
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II AT(1) and AT(2) receptors contribute to maintain basal adrenomedullary norepinephrine synthesis and tyrosine hydroxylase transcription.
Jezova M; Armando I; Bregonzio C; Yu ZX; Qian S; Ferrans VJ; Imboden H; Saavedra JM
Endocrinology; 2003 May; 144(5):2092-101. PubMed ID: 12697718
[TBL] [Abstract][Full Text] [Related]
40. Chronic peripheral administration of the angiotensin II AT(1) receptor antagonist candesartan blocks brain AT(1) receptors.
Nishimura Y; Ito T; Hoe K; Saavedra JM
Brain Res; 2000 Jul; 871(1):29-38. PubMed ID: 10882779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
